Adtalem Global Education (NYSE:CVSA) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen upgraded shares of Adtalem Global Education (NYSE:CVSA) from a hold rating to a buy rating in a research report released on Saturday.

CVSA has been the topic of several other reports. Truist Financial raised their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Finally, Barrington Research reiterated an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a research note on Monday, June 8th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $155.00.

Adtalem Global Education Trading Up 13.3%

NYSE CVSA opened at $140.84 on Friday. Adtalem Global Education has a 12 month low of $86.97 and a 12 month high of $156.26. The company has a market cap of $4.79 billion, a PE ratio of 20.01, a price-to-earnings-growth ratio of 1.06 and a beta of 0.62. The business’s 50 day moving average price is $124.68. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.70 and a current ratio of 0.70.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.19. The business had revenue of $501.38 million for the quarter. Adtalem Global Education had a net margin of 12.87% and a return on equity of 21.05%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Sell-side analysts forecast that Adtalem Global Education will post 8.95 EPS for the current year.

Insider Transactions at Adtalem Global Education

In other Adtalem Global Education news, SVP Douglas G. Beck sold 2,650 shares of Adtalem Global Education stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $135.40, for a total value of $358,810.00. Following the sale, the senior vice president directly owned 35,509 shares in the company, valued at approximately $4,807,918.60. The trade was a 6.94% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert J. Phelan sold 2,900 shares of the business’s stock in a transaction on Tuesday, July 7th. The stock was sold at an average price of $135.41, for a total transaction of $392,689.00. Following the completion of the sale, the chief financial officer owned 52,906 shares in the company, valued at approximately $7,164,001.46. The trade was a 5.20% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 15,694 shares of company stock valued at $2,098,614. 2.50% of the stock is currently owned by corporate insiders.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.